Zhen Cai

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 41

Top Topics

Acute Myeloid Leukemia

Bioinformatics Analysis

Multiple Myeloma

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Cancer medicine

Targeted oncology

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Dian Jin, Haoguang Chen, Jingsong He, Yi Li, Gaofeng Zheng, Yang Yang, Yi Zhao, Jing Le, Wenxiu Shu, Donghua He, Zhen Cai
Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia. Targeted oncology 19 (2) (2024)
Lingling Wang, Lei Yang, Fangshu Guan, Jing Chen, Yuexin Cheng, Yuqing Miao, Jingsong He, Zhen Cai, He Huang, Yi Zhao
TP53 and KMT2D mutations associated with worse prognosis in peripheral T-cell lymphomas. Cancer medicine 13 (14) (2024)
Dian Jin, Haoguang Chen, Jingsong He, Yi Li, Gaofeng Zheng, Yang Yang, Yi Zhao, Jing Le, Wenxiu Shu, Donghua He, Zhen Cai
Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia. Targeted oncology 19 (2) (2024)
Xiaoyan Han, Xincheng Jiang, Jingsong He, Gaofeng Zheng, Yaqin Xiong, Yanling Wen, Yang Yang, Donghua He, Qingxiao Chen, Yi Zhao, Yi Li, Wenjun Wu, Zhen Cai
Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in China. Cancer medicine 13 (9) (2024)
Jin-Na Zhang, Meng-Meng Dong, Wen Cao, Hao-Guang Chen, Hui-Yao Gu, Yi-Li Feng, En-Fan Zhang, Jing-Song He, Si-Cheng Liu, An-Yong Xie, Zhen Cai
Disruption of DNA-PKcs-mediated cGAS retention on damaged chromatin potentiates DNA damage-inducing agent-induced anti-multiple myeloma activity. British journal of cancer 131 (3) (2024)
Jin-Na Zhang, Meng-Meng Dong, Wen Cao, Hao-Guang Chen, Hui-Yao Gu, Yi-Li Feng, En-Fan Zhang, Jing-Song He, Si-Cheng Liu, An-Yong Xie, Zhen Cai
Disruption of DNA-PKcs-mediated cGAS retention on damaged chromatin potentiates DNA damage-inducing agent-induced anti-multiple myeloma activity. British journal of cancer 131 (3) (2024)
Yuqin Song, Zhengming Jin, Zhi-Ming Li, Yan-Yan Liu, Lanfang Li, Chuan He, Hang Su, Hui Zhou, Kunyan Li, Siguo Hao, Xuelan Zuo, Jianyuan Wu, Xiaojian Zhu, Meng Wu, Xiuhua Sun, Junyuan Qi, Zhen Cai, Zhenjiang Li, Yijing Li, Yanhua Huang, Jie Shen, Zhenyu Xiao, Jun Zhu
Enhancer of zeste homolog 2 inhibitor SHR2554 in relapsed or refractory peripheral T-cell lymphoma: data from the first-in-human phase 1 study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Dian Jin, Haoguang Chen, Jingsong He, Yi Li, Gaofeng Zheng, Yang Yang, Yi Zhao, Jing Le, Wenxiu Shu, Donghua He, Zhen Cai
Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia. Targeted oncology 19 (2) (2024)
Dian Jin, Haoguang Chen, Jingsong He, Yi Li, Gaofeng Zheng, Yang Yang, Yi Zhao, Jing Le, Wenxiu Shu, Donghua He, Zhen Cai
Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia. Targeted oncology 19 (2) (2024)
Jin-Na Zhang, Meng-Meng Dong, Wen Cao, Hao-Guang Chen, Hui-Yao Gu, Yi-Li Feng, En-Fan Zhang, Jing-Song He, Si-Cheng Liu, An-Yong Xie, Zhen Cai
Disruption of DNA-PKcs-mediated cGAS retention on damaged chromatin potentiates DNA damage-inducing agent-induced anti-multiple myeloma activity. British journal of cancer 131 (3) (2024)
Yuqin Song, Zhengming Jin, Zhi-Ming Li, Yan-Yan Liu, Lanfang Li, Chuan He, Hang Su, Hui Zhou, Kunyan Li, Siguo Hao, Xuelan Zuo, Jianyuan Wu, Xiaojian Zhu, Meng Wu, Xiuhua Sun, Junyuan Qi, Zhen Cai, Zhenjiang Li, Yijing Li, Yanhua Huang, Jie Shen, Zhenyu Xiao, Jun Zhu
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Dian Jin, Jingsong He, Haoguang Chen, Wenjun Wu, Xiaoyan Han, Jing Le, Wenxiu Shu, Qianqian Yang, Shanshan Pei, Zhen Cai, Donghua He
Impact of monocytic differentiation on acute myeloid leukemia patients treated with venetoclax and hypomethylating agents. Cancer medicine 13 (14) (2024)
Fangshu Guan, Luxin Yang, Yi Chen, Jimin Shi, Xiaolu Song, Xiaoyu Lai, Ying Lu, Lizhen Liu, Guifang Ouyang, Yanmin Zhao, Jian Yu, Yang Xu, Jianping Lan, Huarui Fu, Yi Zhao, Xi Qiu, Panpan Zhu, Zhen Cai, He Huang, Yi Luo
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective study. Cancer (2024)
Dian Jin, Haoguang Chen, Jingsong He, Yi Li, Gaofeng Zheng, Yang Yang, Yi Zhao, Jing Le, Wenxiu Shu, Donghua He, Zhen Cai
Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia. Targeted oncology (2024)
Dian Jin, Jingsong He, Haoguang Chen, Wenjun Wu, Xiaoyan Han, Jing Le, Wenxiu Shu, Qianqian Yang, Shanshan Pei, Zhen Cai, Donghua He
Impact of monocytic differentiation on acute myeloid leukemia patients treated with venetoclax and hypomethylating agents. Cancer medicine 13 (14) (2024)
Xiaoyan Han, Xincheng Jiang, Jingsong He, Gaofeng Zheng, Yaqin Xiong, Yanling Wen, Yang Yang, Donghua He, Qingxiao Chen, Yi Zhao, Yi Li, Wenjun Wu, Zhen Cai
Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in China. Cancer medicine 13 (9) (2024)
Jin-Na Zhang, Meng-Meng Dong, Wen Cao, Hao-Guang Chen, Hui-Yao Gu, Yi-Li Feng, En-Fan Zhang, Jing-Song He, Si-Cheng Liu, An-Yong Xie, Zhen Cai
Disruption of DNA-PKcs-mediated cGAS retention on damaged chromatin potentiates DNA damage-inducing agent-induced anti-multiple myeloma activity. British journal of cancer (2024)
Fangshu Guan, Luxin Yang, Yi Chen, Jimin Shi, Xiaolu Song, Xiaoyu Lai, Ying Lu, Lizhen Liu, Guifang Ouyang, Yanmin Zhao, Jian Yu, Yang Xu, Jianping Lan, Huarui Fu, Yi Zhao, Xi Qiu, Panpan Zhu, Zhen Cai, He Huang, Yi Luo
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective study. Cancer 130 (12) (2024)
Fangshu Guan, Luxin Yang, Yi Chen, Jimin Shi, Xiaolu Song, Xiaoyu Lai, Ying Lu, Lizhen Liu, Guifang Ouyang, Yanmin Zhao, Jian Yu, Yang Xu, Jianping Lan, Huarui Fu, Yi Zhao, Xi Qiu, Panpan Zhu, Zhen Cai, He Huang, Yi Luo
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective study. Cancer 130 (12) (2024)
Lingling Wang, Lei Yang, Fangshu Guan, Jing Chen, Yuexin Cheng, Yuqing Miao, Jingsong He, Zhen Cai, He Huang, Yi Zhao
TP53 and KMT2D mutations associated with worse prognosis in peripheral T-cell lymphomas. Cancer medicine 13 (14) (2024)
Lingling Wang, Lei Yang, Fangshu Guan, Jing Chen, Yuexin Cheng, Yuqing Miao, Jingsong He, Zhen Cai, He Huang, Yi Zhao
TP53 and KMT2D mutations associated with worse prognosis in peripheral T-cell lymphomas. Cancer medicine 13 (14) (2024)
Dian Jin, Jingsong He, Wenjun Wu, Xiaoyan Han, Jing Le, Wenxiu Shu, Jiaping Fu, Hongwei Kong, Gang Wang, Xiujie Zhou, Zhigang Qu, Zhen Cai, Donghua He
Outcomes of COVID-19 in multiple myeloma patients treated with daratumumab. Cancer science (2023)
Jing Chen, Wen Cao, Xi Huang, Qingxiao Chen, Shuting Ye, Jianwei Qu, Yang Liu, Xing Guo, Shunnan Yao, Enfan Zhang, Jingsong He, Anqi Li, Li Yang, Zhen Cai
TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy. Blood advances (2023)
Hong Hu Zhu, Ya-Zhen Qin, Zhang-Lin Zhang, Yong-Jing Liu, Lijun Wen, M James You, Cheng Zhang, Esperanza Such, Hong Luo, Hongjian Yuan, Hong-Sheng Zhou, Hongxing Liu, Ren Xu, Ji Li, Jian-Hu Li, Jian-Ping Hao, Jie Jin, Liang Yu, Jing-Ying Zhang, Li-Ping- Liu, Le-Ping Zhang, Rui-Bin Huang, Shuhong Shen, Sujun Jun Gao, Wei Wang, Xiao-Jing Yan, Xinyou Zhang, Xin Du, Xiaoxia Chu, Yanfang Yu, Yi Wang, Ying-Chang Mi, Ying Lu, Zhen Cai, Zhan Su, David Christopher C Taussig, Suzanne MacMahon, Edward D Ball, Huan-You Wang, John S S Welch, Cheng Cameron Yin, Gautam Borthakur, Miguel Angel Sanz, Hagop M Kantarjian, Jin Yan Huang, Jiong Hu, Su-Ning Chen
A global study for acute myeloid leukemia with RARG rearrangement. Blood advances (2023)
Jing Chen, Wen Cao, Xi Huang, Qingxiao Chen, Shuting Ye, Jianwei Qu, Yang Liu, Xing Guo, Shunnan Yao, Enfan Zhang, Jingsong He, Anqi Li, Li Yang, Zhen Cai
TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy. Blood advances (2023)
Tingyu Wang, Xiuhua Sun, Lihua Qiu, Hang Su, Junning Cao, Zhi-Ming Li, Yuqin Song, Li Zhang, Xiaojian Zhu, Huijing Wu, Wei Zhang, Junmin Li, Ke-Shu Zhou, Hui Zhou, Yu Yang, Zhifeng Li, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, Fei Li, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zhenjiang Li, Shuhua Yi, Hanying Bao, Zusheng Xu, Lugui Qiu
The oral PI3Kδ inhibitor linperlisib for the treatment of relapsed and/or refractory follicular lymphoma: A phase 2, single-arm, open-label clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jing Chen, Wen Cao, Xi Huang, Qingxiao Chen, Shuting Ye, Jianwei Qu, Yang Liu, Xing Guo, Shunnan Yao, Enfan Zhang, Jingsong He, Anqi Li, Li Yang, Zhen Cai
TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy. Blood advances (2023)
Jing Chen, Wen Cao, Xi Huang, Qingxiao Chen, Shuting Ye, Jianwei Qu, Yang Liu, Xing Guo, Shunnan Yao, Enfan Zhang, Jingsong He, Anqi Li, Li Yang, Zhen Cai
TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy. Blood advances (2023)
Jianwei Qu, Haimeng Yan, Yifan Hou, Wen Cao, Yang Liu, Enfan Zhang, Jingsong He, Zhen Cai
RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential. Journal of hematology & oncology 15 (1) (2022)
Yang Liu, Haimeng Yan, Huiyao Gu, Enfan Zhang, Jingsong He, Wen Cao, Jianwei Qu, Ruyi Xu, Liqin Cao, Donghua He, Jinna Zhang, Yifan Hou, Zhen Cai
Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis. Oncoimmunology 11 (1) (2022)
Haimeng Yan, Donghua He, Jianwei Qu, Yang Liu, Ruyi Xu, Huiyao Gu, Jing Chen, Yi Li, Enfan Zhang, Yi Zhao, Jingsong He, Zhen Cai
Interleukin-32γ promotes macrophage-mediated chemoresistance by inducing CSF1-dependent M2 macrophage polarization in multiple myeloma. Cancer immunology, immunotherapy : CII (2022)
Xi Huang, Wen Cao, Shunnan Yao, Jing Chen, Yang Liu, Jianwei Qu, Yi Li, Xiaoyan Han, Jingsong He, He Huang, Enfan Zhang, Zhen Cai
NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma. Cell death & disease 13 (3) (2022)
Jianwei Qu, Yifan Hou, Qingxiao Chen, Jing Chen, Yi Li, Enfan Zhang, Huiyao Gu, Ruyi Xu, Yang Liu, Wen Cao, Jinna Zhang, Liqin Cao, Jingsong He, Zhen Cai
RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways. Oncogene (2021)
Yang Liu, Ruyi Xu, Huiyao Gu, Enfan Zhang, Jianwei Qu, Wen Cao, Xi Huang, Haimeng Yan, Jingsong He, Zhen Cai
Metabolic reprogramming in macrophage responses. Biomarker research 9 (1) (2021)
Xiaoyan Han, Chunxiang Jin, Gaofeng Zheng, Yi Li, Yungui Wang, Enfan Zhang, Honghu Zhu, Zhen Cai
Acute myeloid leukemia with CPSF6-RARG fusion resembling acute promyelocytic leukemia with extramedullary infiltration. Therapeutic advances in hematology 12 (2021)
Yang Yang, Yi Li, Huiyao Gu, Mengmeng Dong, Zhen Cai
Emerging agents and regimens for multiple myeloma. Journal of hematology & oncology 13 (1) (2020)
Xiuhua Wu, Yang Liu, Enfan Zhang, Jing Chen, Xi Huang, Haimeng Yan, Wen Cao, Jianwei Qu, Huiyao Gu, Ruyi Xu, Jingsong He, Zhen Cai
Dihydroartemisinin Modulates Apoptosis and Autophagy in Multiple Myeloma through the P38/MAPK and Wnt/β-Catenin Signaling Pathways. Oxidative medicine and cellular longevity 2020 (2020)
Haimeng Yan, Gaofeng Zheng, Jianwei Qu, Yang Liu, Xi Huang, Enfan Zhang, Zhen Cai
Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis. Journal of cellular physiology 234 (12) (2019)
Haimeng Yan, Jianwei Qu, Wen Cao, Yang Liu, Gaofeng Zheng, Enfan Zhang, Zhen Cai
Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis. Cancer immunology, immunotherapy : CII 68 (12) (2019)
Xi Huang, Huiyao Gu, Enfan Zhang, Qingxiao Chen, Wen Cao, Haimeng Yan, Jing Chen, Li Yang, Ning Lv, Jingsong He, Qing Yi, Zhen Cai
The NEDD4-1 E3 ubiquitin ligase: A potential molecular target for bortezomib sensitivity in multiple myeloma. International journal of cancer 146 (7) (2019)
Yang Yang, Gang Wang, Wenjun Wu, Shunnan Yao, Xiaoyan Han, Donghua He, Jingsong He, Gaofeng Zheng, Yi Zhao, Zhen Cai, Rui Yu
Camalexin Induces Apoptosis via the ROS-ER Stress-Mitochondrial Apoptosis Pathway in AML Cells. Oxidative medicine and cellular longevity 2018 (2018)